Bluestar genomics + press release
WebMay 12, 2024 · Series C investments and scientific advisory board membership expansion are largely inspired by Bluestar Genomics' groundbreaking technology platform that … WebJan 27, 2024 · Excerpt from the Press Release: SAN DIEGO–(BUSINESS WIRE)–Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy approaches initially focused on non-invasive detection of high-mortality cancers, today announced positive performance …
Bluestar genomics + press release
Did you know?
WebMay 12, 2024 · SAN DIEGO-- ( BUSINESS WIRE )-- Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early … WebOct 10, 2024 · Press Release Bluestar Genomics Receives CAP Accreditation for Its Clinical Laboratory Published: Oct. 10, 2024 at 8:00 a.m. ET CAP-accredited, CLIA-certified laboratory positions company...
WebJun 15, 2024 · The case is 3:21-cv-04507, Bluestar Genomics v. Song et al. This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates … Web1 day ago · SAN DIEGO, April 13, 2024 -- ( BUSINESS WIRE )--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform ...
WebMay 12, 2024 · Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board - ClearNote Health Our Story Our Approach Our Tests Test Ordering Our … WebDec 21, 2024 · SAN DIEGO-- ( BUSINESS WIRE )-- Bluestar Genomics today announced the company’s U.S. and international commercialization of its first test for early detection of pancreatic cancer in high-risk patients, and unveiled a new name, ClearNote Health™.
WebSep 12, 2024 · Press release content from Business Wire. The AP news staff was not involved in its creation. Bluestar Genomics Presents Data on New Applications of its …
hw1p-5q4oWebJan 20, 2024 · Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer through a standard blood draw, earlier... mas associate salaryWebPress Releases March 8, 2016 – Courtagen and Medicinal Genomics Announce Expanded Speaker List for CannMed 2016 – 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April The conference will feature internationally recognized thought leaders, scientists, physicians, and advocates working to advance research into … masa son investing in usWebDec 21, 2024 · SAN DIEGO, December 21, 2024 -- ( BUSINESS WIRE )--Bluestar Genomics today announced the company’s U.S. and international commercialization of its first test for early … masa speech therapyWebDec 21, 2024 · Bluestar Genomics Advances to Commercial Phase, Rebrands as ClearNote Health - ClearNote Health Our Story Our Approach Our Tests Test Ordering … hw1p-2q4pw idecWebMar 31, 2024 · Bluestar Genomics announces today it received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its proprietary noninvasive pancreatic cancer detection test in... mas ashlandWebSep 12, 2024 · Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer through a standard blood draw, earlier than existing methods and when the disease is … mas associate linkedin